Johnson & Johnson’S TAR-200 Monotherapy Achieves High Disease-Free Survival Of More Than 80 Percent In BCG-Unresponsive, High-Risk Papillary NMIBC
26 Apr 2025 20:00 GMT
… statements” as defined in the Private Securities Litigation Reform Act of 1995 …
A. O. Smith Announces Kevin Wheeler to Become Executive Chairman, Stephen Shafer Named President and Chief Executive Officer
26 Apr 2025 17:54 GMT
… ; within the meaning of the Private Securities Litigation Reform Act of 1995 …
AbbVie Reports First-Quarter 2025 Financial Results
26 Apr 2025 17:54 GMT
… statements for purposes of the Private Securities Litigation Reform Act of 1995 …
UroGen Pharma Announces Encouraging Results from a Phase 1 Dose-Escalation Study Evaluating UGN-301 in Non-Muscle Invasive Bladder Cancer
26 Apr 2025 14:14 GMT
… term is defined in the Private Securities Litigation Reform Act of 1995 …
Webster Financial Corporation (NYSE:WBS) Q1 2025 Earnings Call Transcript
26 Apr 2025 12:58 GMT
… within the meaning of the Private Securities Litigation Reform Act of 1995 …